146
Views
54
CrossRef citations to date
0
Altmetric
Original Research

Lactobacillus rhamnosus LC705 Together with Propionibacterium freudenreichii ssp shermanii JS Administered in Capsules Is Ineffective in Lowering Serum Lipids

, PhD, , PhD, , PhD, , PhD & , PhD
Pages 441-447 | Received 24 Sep 2007, Accepted 03 Apr 2008, Published online: 14 Jun 2013

REFERENCES

  • Montrose DC, Floch MH: Probiotics used in human studies. J Clin Gastroenterol39 :469– 484,2005 .
  • O'Sullivan MG, Thornton G, O'Sullivan GC, Collins JK: Probiotic bacteria: myth or reality? Trends Food Sci Technol3 :309– 314,1992 .
  • Mann GV, Spoerry A: Studies of a surfactant and cholesteremia in the Maasai. Am J Clin Nutr27 :464– 469,1974 .
  • Pereira DIA, Gibson GR: Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol37 :259– 281,2002 .
  • Somkuti GA, Johnson TL: Cholesterol uptake by Propionibacterium freudenreichii. Curr Microbiol20 :305– 309,1990 .
  • Pereira DIA, Gibson GR: Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol68 :4689– 4693,2002 .
  • Liong MT, Shah NP: Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J Dairy Sci88 :55– 66,2005 .
  • du Toit M, Franz CMAP, Dicks LMT, Schillinger U, Haberer P, Warlies B, Ahrens F, Holzapfel WH: Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. Intern J Food Microbiol40 :93– 104,1998 .
  • Pereira DIA, McCartney AL, Gibson GR: An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Environ Microbiol69 :4743– 4752,2003 .
  • Ridlon JM, Kang D-J, Hylemon PB: Bile salt biotransformations by human intestinal bacteria. J Lipid Res47 :241– 259,2006 .
  • Broccali G, Berti M, Pistolesi E, Cestaro B: Study of the effect of lactobacillus GG supplementation in combination with and without arginine aspartate on lipoproteins and liver peroxidation in cholesterol-fed rats. Intern J Food Sci Nutr51 :475– 482,2000 .
  • Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, Iwatsuki K, Kokubo S, Hosono A: Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci86 :2452– 2461,2003 .
  • Chiu C-H, Lu T-Y, Tseng Y-Y, Pan T-M: The effects of Lactobacillus-fermented milk on lipid metabolism in hamsters fed on high-cholesterol diet. Appl Microbiol Biotechnol71 :238– 245,2006 .
  • St-Onge M-P, Farnworth ER, Jones PJH: Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. Am J Clin Nutr71 :674– 681,2000 .
  • Hepner G, Fried R, St. Jeor S, Fusetti L, Morin R: Hypocholesterolemic effect of yogurt and milk. Am J Clin Nutr32 :19– 24,1979 .
  • Agerbjk M, Gerdes LU, Richelsen B: Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr49 :346– 352,1995 .
  • Richelsen B, Kristensen K, Pedersen SB: Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins - a placebo-controlled and double blind study. Eur J Clin Nutr50 :811– 815,1996 .
  • Bukowska H, Pieczul-Mróz J, Jastrzebska M, Chelstowski, Naruszewicz M: Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis137 :437– 438,1998 .
  • Schaafsma G, Meuling WJA, van Dokkum W, Bouley C: Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr52 :436– 440,1998 .
  • Bertolami MC, Faludi AA, Batlouni M: Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr53 :97– 101,1999 .
  • Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A: Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr54 :288– 297,2000 .
  • Massey LK: Effect of changing milk and yogurt consumption on human nutrient intake and serum lipoproteins. J Dairy Sci67 :255– 262,1984 .
  • Andersson H, Bosaeus I, Ellegård L, Grahn E, Tidehag P, Hallmans G, Holm S, Sandberg AS: Effects of low-fat milk and fermented low-fat milk on cholesterol absorption and excretion in ileostomy subjects. Eur J Clin Nutr49 :274– 281,1995 .
  • de Roos NM, Schouten G, Katan MB: Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur J Clin Nutr53 :277– 280,1999 .
  • Naruszewicz M, Johansson M-L, Zapolska-Downar D, Bukowska H: Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr76 :1249– 1255,2002 .
  • Fabian E, Elmadfa I: Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann Nutr Metab50 :387– 393,2006 .
  • Kiessling G, Schneider J, Jahreis G: Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr56 :843– 849,2002 .
  • Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A: The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr54 :856– 860,2000 .
  • Vaskonen T: Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem14 :492– 506,2003 .
  • Myllyluoma E, Kajander K, Mikkola H, Kyrönpalo S, Rasmussen M, Kankuri E, Sipponen P, Vapaatalo H, Korpela R: Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection. Dig Liver Dis39 :516– 523,2007 .
  • Suomalainen T, Sigvart-Mattila P, Mättö J, Tynkkynen S: In vitro and in vivo gastrointestinal survival, antibiotic susceptibility and genetic identification of Propionibacterium freudenreichii ssp. shermanii JS. Int Dairy J18 :271– 278,2008 .
  • Kirjavainen PV, El-Nezami HS, Salminen SJ, Ahokas JT, Wright PFA: Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation. Clin Diag Lab Immunol6 :799– 802,1999 .
  • Kirjavainen PV, El-Nezami HS, Salminen SJ, Ahokas JT, Wright PFA: The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol Med Microbiol26 :131– 135,1999 .
  • Gratz S, Mykkänen H, El-Nezami H: Aflatoxin B1 binding by a mixture of Lactobacillus and Propionibacterium: in vitro versus ex vivo. J Food Protect68 :2470– 2474,2005 .
  • Ouwehand AC, Langström H, Suomalainen T, Salminen S: Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab46 :159– 162,2002 .
  • El-Nezami HS, Polychronaki NN, Ma J, Zhu H, Ling W, Salminen EK, Juvonen RO, Salminen SJ, Poussa T, Mykkänen HM: Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am J Clin Nutr83 :1199– 1203,2006 .
  • Friedewald WT, Levy RJ, Frederickson DS: Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem18 :499– 509,1972 .
  • Tynkkynen S, Satokari R, Saarela M, Mattila-Sandholm T, Saxelin M: Comparison of ribotyping, randomly amplified polymorphic DNA analysis, and pulsed-field gel electrophoresis in typing of Lactobacillus rhamnosus and L. casei strains. Appl Environ Microbiol65 :3908– 3914,1999 .
  • Lewis SJ, Burmeister S: A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids. Eur J Clin Nutr59 :776– 780,2005 .
  • Larsen CN, Nielsen S, Kaestel P, Brockmann E, Bennedsen M, Christensen HR, Eskesen DC, Jacobsen BL, Michaelsen KF: Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur J Clin Nutr60 :1284– 1293,2006 .
  • Simons LA, Amansec SG, Conway P: Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis16 :531– 535,2006 .
  • Greany KA, Bonorden MJL, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, Feirtag J, Thomas W, Kurzer MS: Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr62 :232– 237,2008 .
  • Lassig A, Karjalainen H, Saxelin M, Surakka A, Tynkkynen S, Vapaatalo H, Korpela R, Hatakka K: Oral and intestinal survival of probiotics given in different food matrixes. A poster presented at SSA GutImpact: 3rd Platform Meeting on Foods for Intestinal Health, 29–31 August2007 , Haikko, Finland.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.